encorafenib,binimetinib
pfizer,ono pharma,pierre fabre
['nsclc', 'binimetinib', 'encorafenib', 'sclc']
 #asco23 simultaneous publication in #jco by gregory riely et al: phase ii, open-label study of encorafenib plus binimetinib in patients with metastatic brafv600-mutant #nsclc 
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.